Liquidia Surges Nearly 37% After Settling United Therapeutics Litigation
Liquidia shares jumped nearly 37% in premarket trading after the drugmaker settled a years-long legal dispute with United Therapeutics over its lung disease drug. The settlement ends six lawsuits over patents, trade secrets and contracts.